Cargando…
COVID-19 and biomarkers of thrombosis: focus on von Willebrand factor and extracellular vesicles
COVID-19, caused by the SARS-CoV-2 virus, is responsible for a pandemic of unparalleled portion over the past century. While the acute phase of infection causes significant morbidity and mortality, post-acute sequelae that can affect essentially any organ system is rapidly taking on an equally large...
Autores principales: | Becker, Richard C., Sexton, Travis, Smyth, Susan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336902/ https://www.ncbi.nlm.nih.gov/pubmed/34350541 http://dx.doi.org/10.1007/s11239-021-02544-x |
Ejemplares similares
-
Porcine and Canine von Willebrand Factor and von Willebrand Disease: Hemostasis, Thrombosis, and Atherosclerosis Studies
por: Nichols, Timothy C., et al.
Publicado: (2010) -
The von Willebrand factor stamps plasmatic extracellular vesicles from glioblastoma patients
por: Sabbagh, Quentin, et al.
Publicado: (2021) -
von Willebrand Factor, Free Hemoglobin and Thrombosis in ECMO
por: Valladolid, Christian, et al.
Publicado: (2018) -
The Role of Von Willebrand Factor in the Pathogenesis of Pulmonary Vascular Thrombosis in COVID-19
por: Babkina, Anastasiya S., et al.
Publicado: (2022) -
Von Willebrand Factor Activity in Thrombosis: An Overlooked Target for Intervention?
por: Shalmi, Theodor W., et al.
Publicado: (2021)